期刊文献+

生长激素瘤并发糖尿病患者胰岛素抵抗的临床观察(附23例报告) 被引量:3

下载PDF
导出
摘要 生长激素瘤使膜化骨形成增加致骨增宽增厚,若高垂体生长激素( GH)血症发生于骨骺关闭以后,则长骨不能延长,但骨量相对增加,骨骼增宽增厚,表现为特殊的外貌。临床上以骨关节症状为常见。垂体生长激素瘤( growth hormone tumor;GH瘤)与糖代谢密切相关,垂体瘤分泌GH过多,有导致糖尿病( diabetes mellitns , DM )的倾向。国外报道其DM的发生率在24%~50%[1,2],是较常见的继发性DM之一。现总结我院2007年1月至2011年1月收治的42例GH瘤患者,合并DM者23例。结合临床表现,观察治疗前后血糖指标及其胰岛素敏感性指数变化。探讨GH瘤患者与胰岛素抵抗( insulin resistance ,IR)的关系。
出处 《湖北科技学院学报(医学版)》 2014年第1期36-37,共2页 Journal of Hubei University of Science and Technology(Medical Sciences)
  • 相关文献

同被引文献35

  • 1Ross JL,Lee PA, Gut R, et al.Increased height standard deviation scores in response to growth hormone therapy to near-aduh height in older children with delayed skeletal maturation: results from the ANSWER Program[J].Int J Pediatr Endocrinol, 2015, 1:1-9.
  • 2Victoria Borr:ts P6rez, Juan Pedro L6pez-Siguero, Martinez G, et al. A Follow- up Study to Monitor Adult Height Among Spanish Children with Growth Hormone Deficiency Who Received Biosimilar Human Recombinant Growth Hormone (Omnitrope:) During a Phase III Clinical Trial[J]. Adv Ther, 2015, 32(2):148-156.
  • 3Raben MS. Treatment of a pituitary dwarf with human growth hormone [J]. Clin Endocrinol Metab, 1958, 18(8):901-903.
  • 4Souza FM, Collett-Solberg PF. Adverse effects of growth hormone replacement therapy in children[J].Arq Bras Endocrinol Metabol, 2011, 55(8):559-565.
  • 5Aycan Z, Ba, VN. Prader-Willi Syndrome and Growth Hormone Deficiency[J].J Clin Res Pediatr Endocrinol, 2014,6 (2):62-67.
  • 6Price DA, Wilton P, Jsnsson P, et al. Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996[J]. Horm Res, 1998, 49(2):91-97.
  • 7Child CJ, Zimmermann AG, Scott RS, et al. Prevalence and incidence of diabetes mellitus in GH- treated children and adolescents: analysis from the GeNeSIS observational research program[J].: Clin Endocrinol Metab, 2011, 96(6):E1025-1034.
  • 8Paul BK, Dorothy IS, James WF, et al. Characteristics of children with the best and poorest first- and second-year growth during rhGH therapy: data from 25 years of the Genenteeh national cooperative growth study (NCGS)[J]. Int J Pediatr Endoerinol,2013,1(9): 1-9.
  • 9Cuffield WS, Wilton P, Bennmarker H, et al. Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth- hormone treatment[J]. Lancet, 2000, 355(9204):610-613.
  • 10Pfiiffle R, Schwab KO, Marginean O, et al. Design of, and first data from, PATRO Children, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope in children requiring growth hormone treatment[J].Ther Adv E ndocri nol Metab, 2013,4( 1 ):3 - 11.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部